Supervisor Elham AbolFateh
Editor in Chief Mohamed Wadie

Sisi Addresses Virtual Global Vaccine Summit 2020


Thu 04 Jun 2020 | 05:47 PM
H-Tayea

On Thursday, the Egyptian President Abdel Fattah El-Sisi participated in the virtual Global Vaccine Summit, which is hosted by the United Kingdom at the level of heads of states, prime ministers and a number of foreign and health ministers, according to Egypt's Presidency spokesman, Bassam Rady.

Rady said that the summit was held in order to raise billions of dollars to immunize children in developing countries and to discuss how any potential vaccine against the new coronavirus might be distributed globally and fairly.

The event is a pledging conference for the vaccines alliance GAVI, which says the funds will be used to vaccinate about 300 million children in dozens of countries against diseases like malaria, pneumonia and HPV.

El-Sisi's Speech

President Sisi delivered a recorded speech, expressing thanks and appreciation to the United Kingdom for its initiative in holding this important summit.

He added that the event comes in a vital timing, especially in light of the outbreak of the coronavirus, stressing the need to unite all efforts globally to contain the virus spread and work on finding effective vaccine.

During the speech, El Sisi also stressed the necessity of paying much attention to the other infectious diseases that the world had previously sought to stop them from spreading.

He stressed the importance of working to make joint efforts to provide routine vaccines and resuming vaccination campaigns against deadly diseases that could be treated by vaccines.

The Egyptian President indicated that Egypt is closely following-up the current global tests to reach an effective vaccine for coronavirus virus, confirming Egypt's keenness, since the beginning of the crisis, to provide assistance to some friendly world countries in order to alleviate the repercussions of the pandemic, as a sign of global solidarity.

Sisi stressed Egypt's readiness to share its successful experience in applying compulsory vaccination plans that contributed to reducing diseases and deaths rates among children, in addition to conducting clinical tests for new vaccines for the deadly virus.